Enhancer of zeste homolog 2 is a negative regulator of mitochondria- mediated innate immune responses

Journal of Immunology

Volumn 191, Issue 5, 2013, Pages 2614-2623

  Chen, Shuai ^a   Sheng, Chunjie ^a   Liu, Dong ^a   Yao, Chen ^a   Gao, Shijuan ^a   Song, Liping ^a   Jiang, Wei ^a   Li, Jiandong ^a   Huang, Wenlin ^a,b,c  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c Science Park   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEAZANEPLANOCIN A; BETA INTERFERON; CARRIER PROTEINS AND BINDING PROTEINS; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; PROTEIN VISA; RETINOIC ACID INDUCIBLE PROTEIN I; TRANSCRIPTION FACTOR EZH2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CYTOSOL; HELA CELL; IMMUNOSTIMULATION; INFLUENZA A; INNATE IMMUNITY; MACROPHAGE; MDCK CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VERO CELL; VIRUS INHIBITION; VIRUS REPLICATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CERCOPITHECUS AETHIOPS; FLOW CYTOMETRY; HEK293 CELLS; HELA CELLS; HUMANS; IMMUNITY, INNATE; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INFLUENZA A VIRUS; MEMBRANE PROTEINS; MICE; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; NERVE TISSUE PROTEINS; ORTHOMYXOVIRIDAE INFECTIONS; POLYCOMB REPRESSIVE COMPLEX 2; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VERO CELLS;

EID: 84883369480     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1203143     Document Type: Article

References (36)

1. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
2. Loo, Y. M., and M. Gale, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34: 680-692.
3. Barber, M. R., J. R. Aldridge, Jr., R. G. Webster, and K. E. Magor. 2010. Association of RIG-I with innate immunity of ducks to influenza. Proc. Natl. Acad. Sci. USA 107: 5913-5918.
4. Xu, L. G., Y. Y. Wang, K. J. Han, L. Y. Li, Z. Zhai, and H. B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19: 727-740.
5. Hou, F., L. Sun, H. Zheng, B. Skaug, Q. X. Jiang, and Z. J. Chen. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146: 448-461.
6. West, A. P., G. S. Shadel, and S. Ghosh. 2011. Mitochondria in innate immune responses. Nat. Rev. Immunol. 11: 389-402.
7. Margueron, R., and D. Reinberg. 2011. The Polycomb complex PRC2 and its mark in life. Nature 469: 343-349.
8. Viré, E., C. Brenner, R. Deplus, L. Blanchon, M. Fraga, C. Didelot, L. Morey, A. Van Eynde, D. Bernard, J. M. Vanderwinden, et al. 2006. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439: 871-874.
9. Palacios, D., C. Mozzetta, S. Consalvi, G. Caretti, V. Saccone, V. Proserpio, V. E. Marquez, S. Valente, A. Mai, S. V. Forcales, et al. 2010. TNF/p38a/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 7: 455-469.
10. Tsai, M. C., O. Manor, Y. Wan, N. Mosammaparast, J. K. Wang, F. Lan, Y. Shi, E. Segal, and H. Y. Chang. 2010. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693.
11. Lee, T. I., R. G. Jenner, L. A. Boyer, M. G. Guenther, S. S. Levine, R. M. Kumar, B. Chevalier, S. E. Johnstone, M. F. Cole, K. Isono, et al. 2006. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 125: 301-313.
12. Albert, M., and K. Helin. 2010. Histone methyltransferases in cancer. Semin. Cell Dev. Biol. 21: 209-220.
13. Su, I. H., M. W. Dobenecker, E. Dickinson, M. Oser, A. Basavaraj, R. Marqueron, A. Viale, D. Reinberg, C. Wülfing, and A. Tarakhovsky. 2005. Polycomb group protein ezh2 controls actin polymerization and cell signaling. Cell 121: 425-436.
14. Chen, S., L. R. Bohrer, A. N. Rai, Y. Pan, L. Gan, X. Zhou, A. Bagchi, J. A. Simon, and H. Huang. 2010. Cyclin-dependent kinases regulate epigenetic gene silencing through phosphorylation of EZH2. Nat. Cell Biol. 12: 1108-1114.
15. Gao, S., L. Song, J. Li, Z. Zhang, H. Peng, W. Jiang, Q. Wang, T. Kang, S. Chen, and W. Huang. 2012. Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK. Cell. Microbiol. 14: 1849-1866.
16. Cha, T. L., B. P. Zhou, W. Xia, Y. Wu, C. C. Yang, C. T. Chen, B. Ping, A. P. Otte, and M. C. Hung. 2005. Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3. Science 310: 306-310.
17. Takaoka, A., Z. Wang, M. K. Choi, H. Yanai, H. Negishi, T. Ban, Y. Lu, M. Miyagishi, T. Kodama, K. Honda, et al. 2007. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448: 501-505.
18. Tan, J., X. Yang, L. Zhuang, X. Jiang, W. Chen, P. L. Lee, R. K. Karuturi, P. B. Tan, E. T. Liu, and Q. Yu. 2007. Pharmacologic disruption of Polycombrepressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 21: 1050-1063.
19. Kamminga, L. M., L. V. Bystrykh, A. de Boer, S. Houwer, J. Douma, E. Weersing, B. Dontje, and G. de Haan. 2006. The Polycomb group gene Ezh2 prevents hematopoietic stem cell exhaustion. Blood 107: 2170-2179.
20. Su, I. H., A. Basavaraj, A. N. Krutchinsky, O. Hobert, A. Ullrich, B. T. Chait, and A. Tarakhovsky. 2003. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat. Immunol. 4: 124-131.
21. Min, J., A. Zaslavsky, G. Fedele, S. K. McLaughlin, E. E. Reczek, T. De Raedt, I. Guney, D. E. Strochlic, L. E. Macconaill, R. Beroukhim, et al. 2010. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-kappaB. Nat. Med. 16: 286-294.
22. Lee, S. T., Z. Li, Z. Wu, M. Aau, P. Guan, R. K. Karuturi, Y. C. Liou, and Q. Yu. 2011. Context-specific regulation of NF-κB target gene expression by EZH2 in breast cancers. Mol. Cell 43: 798-810.
23. De Santa, F., M. G. Totaro, E. Prosperini, S. Notarbartolo, G. Testa, and G. Natoli. 2007. The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130: 1083-1094.
24. De Santa, F., V. Narang, Z. H. Yap, B. K. Tusi, T. Burgold, L. Austenaa, G. Bucci, M. Caganova, S. Notarbartolo, S. Casola, et al. 2009. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 28: 3341-3352.
25. Kruidenier, L., C. W. Chung, Z. Cheng, J. Liddle, K. Che, G. Joberty, M. Bantscheff, C. Bountra, A. Bridges, H. Diallo, et al. 2012. A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response. Nature 488: 404-408.
26. Srinivasula, S. M., M. Ahmad, T. Fernandes-Alnemri, and E. S. Alnemri. 1998. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol. Cell 1: 949-957.
27. Hiscott, J., R. Lin, P. Nakhaei, and S. Paz. 2006. MasterCARD: a priceless link to innate immunity. Trends Mol. Med. 12: 53-56.
28. Moresco, E. M., D. L. Vine, and B. Beutler. 2011. Prion-like behavior of MAVS in RIG-I signaling. Cell Res. 21: 1643-1645.
29. Jounai, N., F. Takeshita, K. Kobiyama, A. Sawano, A. Miyawaki, K. Q. Xin, K. J. Ishii, T. Kawai, S. Akira, K. Suzuki, and K. Okuda. 2007. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc. Natl. Acad. Sci. USA 104: 14050-14055.
30. Li, Q., J. Qi, W. Zhang, C. J. Vavricka, Y. Shi, J. Wei, E. Feng, J. Shen, J. Chen, D. Liu, et al. 2010. The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site. Nat. Struct. Mol. Biol. 17: 1266-1268.
31. Collins, P. J., L. F. Haire, Y. P. Lin, J. Liu, R. J. Russell, P. A. Walker, J. J. Skehel, S. R. Martin, A. J. Hay, and S. J. Gamblin. 2008. Crystal structures of oseltamivirresistant influenza virus neuraminidase mutants. Nature 453: 1258-1261.
32. Zoabi, M., R. Sadeh, P. de Bie, V. E. Marquez, and A. Ciechanover. 2011. PRAJA1 is a ubiquitin ligase for the polycomb repressive complex 2 proteins. [Published erratum appears in 2011 Biochem. Biophys. Res. Commun. 410: 705.] Biochem. Biophys. Res. Commun. 408: 393-398.
33. De Clercq, E. 1987. S-adenosylhomocysteine hydrolase inhibitors as broadspectrum antiviral agents. Biochem. Pharmacol. 36: 2567-2575.
34. Mayers, D. L., J. A. Mikovits, B. Joshi, I. K. Hewlett, J. S. Estrada, A. D. Wolfe, G. E. Garcia, B. P. Doctor, D. S. Burke, R. K. Gordon, et al. 1995. Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3′-azido-3′-deoxythymidine- resistant HIV-1 strains. Proc. Natl. Acad. Sci. USA 92: 215-219.
35. Bray, M., J. Driscoll, and J. W. Huggins. 2000. Treatment of lethal Ebola virus infection in mice with a single dose of an S-adenosyl-L-homocysteine hydrolase inhibitor. Antiviral Res. 45: 135-147.
36. Barnard, D. L., C. W. Day, K. Bailey, M. Heiner, R. Montgomery, L. Lauridsen, P. K. Chan, and R. W. Sidwell. 2006. Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice. Antivir. Chem. Chemother. 17: 275-284.